Literature DB >> 17761525

Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic.

Fadile Yildiz Zeyrek1, Metin Korkmaz, Yusuf Ozbel.   

Abstract

In this study, we aimed to evaluate the validity of the conventional enzyme-linked immunosorbent assay (ELISA) and the Western blotting test for the diagnosis of anthroponotic cutaneous leishmaniasis (ACL) using serum samples obtained from 51 patients with parasitologically proven nontreated CL (NonT-CL patients) and 62 patients under treatment for CL (UT-CL patients). Additionally, 29 serum samples obtained from patients with parasitologically and serologically proven visceral leishmaniasis (VL) were also used as positive controls, and serum samples from 43 blood donors were used as negative controls. All sera were diluted to the same dilution (1/100). Leishmania infantum MON-1 was used as the antigen in the conventional ELISA. The sera of 27 (93.1%) of 29 VL patients were seropositive by ELISA, while the sera of 40 (78.4%) of 51 NonT-CL patients and 43 (69.3%) of 62 UT-CL patients were seropositive by the conventional ELISA. The absorbance values of the CL patients' sera were significantly lower than the absorbance values of the VL patients' sera. Bands between 15 and 118 kDa were detected in two groups of CL patients. Among all bands, the 63-kDa band was found to be more sensitive (88.5%). When we evaluated the Western blotting results for the presence of at least one of the diagnostic antigenic bands, the sensitivity was calculated to be 99.1%. By using serological tests, a measurable antibody response was detected in most of the CL patients in Sanliurfa, Turkey. It is also noted that this response can be changed according to the sizes, types, and numbers of lesions that the patient has. The Western blot test was found to be more sensitive and valid than the conventional ELISA for the serodiagnosis of ACL. In some instances, when it is very difficult to demonstrate the presence of parasites in the smears, immunodiagnosis can be a valuable alternative for the diagnosis of ACL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761525      PMCID: PMC2168175          DOI: 10.1128/CVI.00133-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  38 in total

1.  Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes.

Authors:  M E Wilson; K K Hardin; J E Donelson
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

2.  Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis.

Authors:  F J Tapia; G Cáceres-Dittmar; M A Sánchez
Journal:  Immunol Today       Date:  1994-04

3.  Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission.

Authors:  J L Sanchez; B M Diniega; J W Small; R N Miller; J M Andujar; P J Weina; P G Lawyer; W R Ballou; J K Lovelace
Journal:  Am J Trop Med Hyg       Date:  1992-07       Impact factor: 2.345

4.  Localized cutaneous leishmaniasis (chiclero's ulcer) in Mexico: sensitivity and specificity of ELISA for IgG antibodies to Leishmania mexicana mexicana.

Authors:  M R Garcia-Miss; F J Andrade-Narvaez; R E Esquivel-Viñas; E B Simmonds-Diaz; S B Canto-Lara; A L Cruz-Ruiz
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 May-Jun       Impact factor: 2.184

5.  Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.

Authors:  D M Yang; N Fairweather; L L Button; W R McMaster; L P Kahl; F Y Liew
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

6.  Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis.

Authors:  L Rolland-Burger; X Rolland; C W Grieve; L Monjour
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Analysis of the specificity of human antibodies to antigens of Leishmania braziliensis braziliensis.

Authors:  A Masuda; S F do Nascimento; C S Guerra; G da S Paranhos; A W Ferreira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1989 Jul-Aug       Impact factor: 1.846

8.  Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.

Authors:  D G Russell; J Alexander
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

9.  The clinical and immunological spectrum of American cutaneous leishmaniasis.

Authors:  J Convit; M Ulrich; C T Fernández; F J Tapia; G Cáceres-Dittmar; M Castés; A J Rondón
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Jul-Aug       Impact factor: 2.184

Review 10.  Serodiagnosis of leishmaniasis.

Authors:  K Kar
Journal:  Crit Rev Microbiol       Date:  1995       Impact factor: 7.624

View more
  16 in total

1.  Leishmania tropica in rock hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasis.

Authors:  Dalit Talmi-Frank; Charles L Jaffe; Abedelmajeed Nasereddin; Alon Warburg; Roni King; Milena Svobodova; Ofer Peleg; Gad Baneth
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  ELISA-based evaluation of antibody response to Leishmania in a region endemic for cutaneous leishmaniasis.

Authors:  Sachee Bhanu Piyasiri; Thisum Nilakshi Samaranayake; Hermali Silva; Nuwani Harshamali Manamperi; Nadira Darshani Karunaweera
Journal:  Parasite Immunol       Date:  2022-08-03       Impact factor: 2.206

3.  Molecular identification of Leishmania spp. isolates causes cutaneous leishmaniasis (CL) in Sanliurfa Province, Turkey, where CL is highly endemic.

Authors:  Gulcan Gurses; Mehmet Ozaslan; Fadile Yıldız Zeyrek; Ibrahim H Kılıç; Nebiye Yentür Doni; I Didem Karagöz; Nermin Uluca
Journal:  Folia Microbiol (Praha)       Date:  2017-12-07       Impact factor: 2.099

4.  Recombinant Leishmania infantum heat shock protein 83 for the serodiagnosis of cutaneous, mucosal, and visceral leishmaniases.

Authors:  Beatriz Julieta Celeste; Maria Carmen Arroyo Sanchez; Eduardo Milton Ramos-Sanchez; Luiz Guilherme M Castro; Francisco Assis Lima Costa; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

5.  Resurgence of cutaneous leishmaniasis in Israel, 2001-2012.

Authors:  Dan Gandacu; Yael Glazer; Emilia Anis; Isabella Karakis; Bruce Warshavsky; Paul Slater; Itamar Grotto
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

Review 6.  Complementary exams in the diagnosis of American tegumentary leishmaniasis.

Authors:  Ciro Martins Gomes; Natália Aparecida de Paula; Orlando Oliveira de Morais; Killarney Ataíde Soares; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

7.  Epidemiological Trends of Cutaneous Leishmaniasis in Al-Madinah Al-Munawarah Province, Western Region of Saudi Arabia.

Authors:  Miskelyemen Abdelatti Elmekki; Mogahid M Elhassan; Hani A Ozbak; Ilham T Qattan; Satti M Saleh; Ali H Alharbi
Journal:  J Glob Infect Dis       Date:  2017 Oct-Dec

8.  Comparative Testing of Susceptibility Levels of Phlebotomus sergenti, the Main Vector of Anthroponotic Cutaneous Leishmaniasis, to Conventional Insecticides Using Two Capture Methods in Kerman City, Southeastern Iran.

Authors:  Yavar Rassi; Shahla Ebrahimi; Mohammad Reza Abai; Hassan Vatandoost; Amir Ahmad Akhavan; Abass Aghaie Afshar
Journal:  J Arthropod Borne Dis       Date:  2021-03-31       Impact factor: 1.198

9.  Performance of an ELISA and indirect immunofluorescence assay in serological diagnosis of zoonotic cutaneous leishmaniasis in iran.

Authors:  Bahador Sarkari; Marzieh Ashrafmansouri; GholamReza Hatam; Parvaneh Habibi; Samaneh Abdolahi Khabisi
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-08-11

10.  Utility of Western Blot Analysis for the Diagnosis of Cutaneous Leishmaniasis.

Authors:  Marzieh Ashrafmansouri; Bahador Sarkari; Gholamreza Hatam; Parvaneh Habibi; Samaneh Abdolahi Khabisi
Journal:  Iran J Parasitol       Date:  2015 Oct-Dec       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.